Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Nodal Staging in Endometrial Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Surgical candidate for complete hysterectomy and bilateral salpingooophorectomy with pelvic and aortic lymphadenectomy~* Histologically or cytologically confirmed endometrioid-type endometrial cancer confined to the uterine corpus~* No clinical evidence of extra-uterine disease on pre-operative evaluation.~* Prior systemic chemotherapy is allowed so long as it was at least five years prior to study enrollment, and there is no evidence of disease after such therapy.~* Age ≥18 years.~* Life expectancy (estimated survival) of at least 6 months.~* AST(SGOT)/ALT(SGPT) \< 3.0X upper limit of normal~* Ability to understand and the willingness to sign a written informed consent document.~Exclusion Criteria:~* GOG/ECOG Performance Status greater than 2~* Non-endometrioid cell type~* Clinical evidence of disease that extends beyond the uterus, including the presence of suspicious aortic or inguinal nodes on imaging or clinical exam~* Previous vaginal, pelvic or abdominal irradiation~* Chemotherapy, hormone therapy or immunotherapy directed at the present disease~* Previous pelvic lymphadenectomy or retroperitoneal surgery~* Patients with a prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen~* Known allergy to iodine or indigocyanine green (ICG) tracer, or allergic reactions to compounds of similar chemical or biologic composition~* Patients with uncontrolled intercurrent illness~* Patients with psychiatric illness/social situations that would limit compliance with study requirements~* Pregnant or lactating women

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sentinel Node Surgical Staging (Type: EXPERIMENTAL): None
- Selective Surgical Staging (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).